GE HealthCare Launches AI-Enabled Ultrasound for Dense BreastsÂ
The AI-powered 3D ultrasound is designed to enhance cancer detection in dense breast tissue by providing clearer imaging, faster scanning, and improved diagnostic confidence.
The AI-powered 3D ultrasound is designed to enhance cancer detection in dense breast tissue by providing clearer imaging, faster scanning, and improved diagnostic confidence.
Siemens Healthineers has received U.S. FDA clearance for the AI-powered Acuson Origin cardiovascular ultrasound system and the AcuNav Lumos 4D ICE catheter, both designed to improve cardiac diagnostics and patient care.
The Sonosite Voice Assist application is a voice command feature that can control Sonosite PX and Sonosite LX systems hands free.
The AI-powered 3D ultrasound is designed to enhance cancer detection in dense breast tissue by providing clearer imaging, faster scanning, and improved diagnostic confidence.
The FDA granted clearance to HistoSonics Histotripsy therapy platform for non-invasive destruction of liver tumors using focused ultrasound.
Read MoreCaption Guidance is an AI-driven technology that provides real-time guidance to users for capturing diagnostic-quality cardiac images.
Read MoreGE HealthCare and University Hospitals (UH) announced a 10-year strategic collaboration to bring GE HealthCare technologies to UH.
Read MoreThe Exo Iris is a handheld ultrasound device designed to put high-performance medical imaging into the hands and pockets of caregivers.Â
Read MoreAUS was selected for the 2023 Best of Tulsa Award in the Medical Equipment Supplier category by the Tulsa Award Program.
Read MoreLimaca Medical’s Precision GI Endoscopic Ultrasound (EUS) Biopsy Device received 510(k) clearance from the FDA.
Read MoreGE HealthCare has launched Vscan Air SL, a handheld wireless ultrasound system designed for quick cardiac and vascular assessments at the point of care.